US Patent:
20160113919, Apr 28, 2016
Inventors:
- Stanford CA, US
Jeffrey S. Glenn - Palo Alto CA, US
Rajiv Lochan Gaur - Palo Alto CA, US
Tran Van - Stanford CA, US
Gary K. Schoolnik - Stanford CA, US
Edward Pham - Stanford CA, US
International Classification:
A61K 31/4706
A61K 45/06
Abstract:
This disclosure provides a method of treating a subject infected with a mycobacteria of the complex or infected with an atypical . Aspects of the method include administering to a subject in need thereof a therapeutically effective amount of an enantiomerically pure (R)-chloroquine agent. The (R)-chloroquine agent may be an analog or derivate of chloroquine having a particular stereochemistry at the position located alpha to the amino-quinoline core of the chloroquine agent. Also provided are methods of inhibiting mycobacteria of the complex or other atypical mycobacteria in a cell. Kits and pharmaceutical compositions for practicing the subject methods are also provided.